Abstract
Background: Hospital-initiated smoking cessation interventions utilizing pharmacotherapy increase post-discharge quit rates. Use of smoking cessation medications following discharge may further increase quit rates. This study aims to identify individual, smoking-related and hospitalization-related predictors of engagement in three different steps in the smoking cessation pharmacotherapy utilization process: 1) receiving medications as inpatient, 2) being discharged with a prescription and 3) using medications at 1-month post-hospitalization, while accounting for associations between these steps. Methods: Study data come from a clinical trial (N = 1054) of hospitalized smokers interested in quitting who were randomized to recieve referral to a quitline via either warm handoff or fax. Variables were from the electronic health record, the state tobacco quitline, and participant self-report. Relationships among the predictors and the steps in cessation medication utilization were assessed using bivariate analyses and multivariable path analysis. Results: Twenty-eight percent of patients reported using medication at 1-month post-discharge. Receipt of smoking cessation medications while hospitalized (OR = 2.09, 95%CI [1.39, 3.15], p
Author supplied keywords
Cite
CITATION STYLE
Liebmann, E. P., Scheuermann, T. S., Faseru, B., & Richter, K. P. (2019). Critical steps in the path to using cessation pharmacotherapy following hospital-initiated tobacco treatment. BMC Health Services Research, 19(1). https://doi.org/10.1186/s12913-019-4059-4
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.